AbbVie completes acquisition of Apogee Therapeutics, deepening immunology pipeline

{
  "signal_id": "c13056ee-e235-42de-b4df-c2b2bec9cb7a",
  "signal_type": "sec-8k",
  "signal_subtype": "acquisitionCompleted",
  "detected_at": "2026-11-03T07:14:27.458+00:00",
  "company": {
    "name": "AbbVie",
    "domain": "abbvie.com"
  },
  "data": {
    "detail": "AbbVie announced it completed its acquisition of Apogee Therapeutics, adding assets including zumilokibart and APG273 to its immunology pipeline. M&A integrations may create vendor opportunities across clinical trial management, lab informatics, and regulatory compliance systems.",
    "summary": "AbbVie completes acquisition of Apogee Therapeutics, deepening immunology pipeline",
    "excerpts": "AbbVie announced it completed its acquisition of Apogee Therapeutics, deepening AbbVie’s robust immunology pipeline with diverse assets targeting dermatologic, respiratory and other inflammatory and immunological diseases.",
    "relevance": 0.85,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115226000033/abbv-20261030.htm",
    "filing_date": "2026-10-30",
    "filing_year": 2026,
    "fiscal_year_end": "10/30",
    "sales_relevance": "Active integration needs",
    "signal_category": "strategic"
  }
}

curl https://signals.autobound.ai/v1/signals/c13056ee-e235-42de-b4df-c2b2bec9cb7a \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"abbvie.com","limit":20}'